Studies on Fibrinolytic System Behavior in Women with Polycystic Ovary Syndrome.
- Author:
Tae Kyu YOON
1
;
Yong Bong KIM
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Inje University, Seoul Paik Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Polycystic ovary syndrome;
Fibrinolytic system;
Plasminogen activator inhibitor-1
- MeSH:
Anovulation;
Female;
Fibrinogen;
Fibrinolysin;
Humans;
Ovary;
Plasma;
Plasminogen;
Plasminogen Activator Inhibitor 1;
Polycystic Ovary Syndrome*;
Rupture
- From:Korean Journal of Obstetrics and Gynecology
2003;46(8):1481-1485
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To evaluate the plasma concentration of plasminogen activator inhibitor 1, main regulator of fibrinolytic system in women with polycystic ovary syndrome and to clarify whether it may be involved in the pathogenesis of chronic anovulation. METHODS: Fibrinolytic system (plasma fibrinogen, plasminogen, plasminogen activator inhibitor 1 concentration) was assayed in women with polycystic ovary syndrome and compared to normal controls. RESULTS: Women with polycystic ovary syndrome had significantly higher plasminogen activator inhibitor 1 and fibrinogen concentration compared to normal controls. CONCLUSION: Women with polycystic ovary syndrome may have an imbalance in the fibrinolytic system that is tilted towards a reduced production of the proteolytic enzyme plasmin. It may result in impaired follicular rupture and anovulation at cellular level in the ovaries.
